{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:45:16Z","timestamp":1790207116120,"version":"4.1.0"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Microbiologically based criteria such as sputum culture conversion to negative have traditionally been used to define treatment success for mycobacterial diseases. There are, however, limited data regarding whether nontuberculous mycobacterial sputum culture conversion or semiquantitative culture analysis correlates with subjective or nonmicrobiologic objective indices of treatment response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To determine whether a semiquantitative mycobacterial culture scale correlated with clinical disease status and was predictive of long-term sputum mycobacterial culture conversion to negative in a cohort of patients with nodular\/bronchiectatic Mycobacterium avium complex lung disease undergoing therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>One hundred and eighty patients undergoing standard macrolide-based therapy for M. avium complex lung disease were monitored at standard frequent intervals with symptomatic, radiographic, and microbiologic data collected, including semiquantitative mycobacterial culture analysis. Analyses were used to evaluate clinical and microbiologic predictors of long-term sputum conversion to culture negative.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>After 12 months of therapy, 148 (82%) patients had sputum conversion to culture negative. Baseline semiquantitative sputum culture scores did not differ between patients with sputum conversion and those without. The change in sputum culture semiquantitative score from baseline to Month 3 was highly predictive of subsequent sputum long-term conversion status indicative of treatment success, as was improvement in cough, and especially early radiographic improvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Early semiquantitative sputum agar plate culture results can be used to predict symptomatic and radiographic improvement as well as long-term sputum culture conversion to negative in this population. We suggest that semiquantitative sputum culture scores can be a useful tool for evaluating new nontuberculous mycobacterial lung disease therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.201503-0444oc","type":"journal-article","created":{"date-parts":[[2015,6,11]],"date-time":"2015-06-11T13:06:58Z","timestamp":1434028018000},"page":"754-760","source":"Crossref","is-referenced-by-count":81,"title":["Semiquantitative Culture Analysis during Therapy for\n                    <i>Mycobacterium avium<\/i>\n                    Complex Lung Disease"],"prefix":"10.1093","volume":"192","author":[{"given":"David E.","family":"Griffith","sequence":"first","affiliation":[{"name":"University of Texas Health Science Center, Tyler, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Adjemian","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland"},{"name":"United States Public Health Service Commissioned Corps, Rockville, Maryland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Brown-Elliott","sequence":"additional","affiliation":[{"name":"University of Texas Health Science Center, Tyler, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie V.","family":"Philley","sequence":"additional","affiliation":[{"name":"University of Texas Health Science Center, Tyler, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Rebecca","family":"Prevots","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Gaston","sequence":"additional","affiliation":[{"name":"University of Texas Health Science Center, Tyler, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth N.","family":"Olivier","sequence":"additional","affiliation":[{"name":"National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Richard J.","family":"Wallace","sequence":"additional","affiliation":[{"name":"University of Texas Health Science Center, Tyler, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,9,15]]},"reference":[{"key":"2026032100183224100_bib1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"2026032100183224100_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1164\/ajrccm.156.2.atsstatement","article-title":"American Thoracic Society; Medical Section of the American Lung Association. Diagnosis and treatment of disease caused by nontuberculous mycobacteria","volume":"156","author":"Wallace","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100183224100_bib3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1513\/AnnalsATS.201207-038OC","article-title":"The association between symptoms and microbiologically defined response to tuberculosis treatment","volume":"10","author":"Hales","year":"2013","journal-title":"Ann Am Thorac Soc"},{"key":"2026032100183224100_bib4","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1164\/ajrccm.149.5.8173775","article-title":"Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease","volume":"149","author":"Wallace","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100183224100_bib5","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1164\/ajrccm.153.6.8665032","article-title":"Clarithromycin regimens for pulmonary Mycobacterium avium complex: the first 50 patients","volume":"153","author":"Wallace","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100183224100_bib6","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1086\/320512","article-title":"Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease","volume":"32","author":"Griffith","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2026032100183224100_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1086\/515597","article-title":"Initial (6-month) results of three-times-weekly azithromycin in treatment regimens for Mycobacterium avium complex lung disease in human immunodeficiency virus\u2013negative patients","volume":"178","author":"Griffith","year":"1998","journal-title":"J Infect Dis"},{"key":"2026032100183224100_bib8","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1378\/chest.13-2538","article-title":"Macrolide\/azalide therapy for nodular\/bronchiectatic Mycobacterium avium complex lung disease","volume":"146","author":"Wallace","year":"2014","journal-title":"Chest"},{"key":"2026032100183224100_bib9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1553-2712.2010.00773.x","article-title":"Risk ratios and odds ratios for common events in cross-sectional and cohort studies","volume":"17","author":"Wilber","year":"2010","journal-title":"Acad Emerg Med"},{"key":"2026032100183224100_bib10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/resp.12440","article-title":"Variable agreement among experts regarding Mycobacterium avium complex lung disease","volume":"20","author":"Marras","year":"2015","journal-title":"Respirology"},{"key":"2026032100183224100_bib11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.7326\/0003-4819-76-3-112-6-407","article-title":"A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis: a twice-weekly, directly observed, and cost-effective regimen","volume":"112","author":"Cohn","year":"1990","journal-title":"Ann Intern Med"},{"key":"2026032100183224100_bib12","first-page":"CD008351","article-title":"Airway clearance techniques for bronchiectasis","volume":"5","author":"Lee","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2026032100183224100_bib13","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.rmed.2011.12.021","article-title":"The long term effect of inhaled hypertonic saline 6% in non\u2013cystic fibrosis bronchiectasis","volume":"106","author":"Nicolson","year":"2012","journal-title":"Respir Med"},{"key":"2026032100183224100_bib14","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.rmed.2011.07.019","article-title":"Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis","volume":"105","author":"Kellett","year":"2011","journal-title":"Respir Med"},{"key":"2026032100183224100_bib15","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.athoracsur.2014.04.049","article-title":"Lung resection improves the quality of life of patients with symptomatic bronchiectasis","volume":"98","author":"Vallilo","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"2026032100183224100_bib16","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s11136-012-0188-5","article-title":"Depression and anxiety symptoms in bronchiectasis: associations with health-related quality of life","volume":"22","author":"Olveira","year":"2013","journal-title":"Qual Life Res"},{"key":"2026032100183224100_bib17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.arbres.2013.01.012","article-title":"Presence of anxiety and depression in patients with bronchiectasis unrelated to cystic fibrosis","volume":"49","author":"Gir\u00f3n Moreno","year":"2013","journal-title":"Arch Bronconeumol"},{"key":"2026032100183224100_bib18","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1183\/09031936.97.10081754","article-title":"Effect of sputum bacteriology on the quality of life of patients with bronchiectasis","volume":"10","author":"Wilson","year":"1997","journal-title":"Eur Respir J"},{"key":"2026032100183224100_bib19","first-page":"CD010327","article-title":"Combination inhaled corticosteroids and long-acting \u03b22-agonists for children and adults with bronchiectasis","volume":"6","author":"Goyal","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2026032100183224100_bib20","article-title":"Laboratory detection and identification of mycobacteria; approved guideline. CLSI document M48-A","author":"Clinical Laboratory Standards Institute","year":"2008"},{"key":"2026032100183224100_bib21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/thorax.55.3.210","article-title":"Management of opportunist mycobacterial infections: Joint Tuberculosis Committee Guidelines 1999","volume":"55","author":"Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society","year":"2000","journal-title":"Thorax"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/192\/6\/754\/67230022\/ajrccm_192_6_754.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/192\/6\/754\/67230022\/ajrccm_192_6_754.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T04:18:39Z","timestamp":1774066719000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/192\/6\/754\/8504835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":21,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,9,15]]},"published-print":{"date-parts":[[2015,9,15]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201503-0444oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,9]]},"published":{"date-parts":[[2015,9]]}}}